Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 23

Trial Status

Completed1
Terminated2

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT00006003Phase 2Terminated
SU5416 in Treating Patients With Metastatic Melanoma That Has Been Previously Treated
Recurrent MelanomaStage IV Melanoma
Principalinvestigator
NCT00669019Phase 2Completed
Saracatinib in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery
Recurrent MelanomaStage IIA MelanomaStage IIB Melanoma+2 more
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

University of Chicago Comprehensive Cancer Center

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jeffrey Weber

University of Southern California

Related
4 trials

Shared therapeutic areas:

Stage IV MelanomaRecurrent MelanomaStage IIC Melanoma+1 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score20%

Paul Chapman

Memorial Sloan Kettering Cancer Center

Related
3 trials

Shared therapeutic areas:

Recurrent MelanomaStage IV MelanomaStage IV Skin Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score15%

Svetomir Markovic

Mayo Clinic

Related
3 trials

Shared therapeutic areas:

Recurrent MelanomaStage IV MelanomaStage IV Skin Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score15%

Joseph Skitzki

Roswell Park Cancer Institute

Related
3 trials

Shared therapeutic areas:

Recurrent MelanomaStage IV Skin Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score10%

Muralidhar Beeram

Cancer Therapy and Research Center at The UT Health Science Center at San Antonio

Related
3 trials

Shared therapeutic areas:

Recurrent MelanomaStage IV Skin Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score10%

Wenyin Shi, MD, PhD

Thomas Jefferson University

Related
5 trials

Shared therapeutic areas:

Recurrent MelanomaStage IV Melanoma
Similarity Score10%

Evanthia Galanis

Mayo Clinic

Related
2 trials

Shared therapeutic areas:

Recurrent MelanomaStage IV Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score10%

Cassian Yee

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

Related
3 trials

Shared therapeutic areas:

Stage IV MelanomaRecurrent Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score10%

David Solit

Memorial Sloan Kettering Cancer Center

Related
2 trials

Shared therapeutic areas:

Recurrent MelanomaStage IV Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score10%

Kevin Kim

M.D. Anderson Cancer Center

Related
3 trials

Shared therapeutic areas:

Stage IV MelanomaRecurrent Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT00006003Phase 2PrincipalInvestigator

SU5416 in Treating Patients With Metastatic Melanoma That Has Been Previously Treated

Recurrent MelanomaStage IV Melanoma
Terminated
NCT00669019Phase 2PrincipalInvestigator

Saracatinib in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery

Recurrent MelanomaStage IIA MelanomaStage IIB Melanoma+2 more
Completed
NCT01307618Phase 2PrincipalInvestigator

Vaccine Therapy With or Without Recombinant Interleukin-12 Followed by Daclizumab in Treating Patients With Metastatic Melanoma

Recurrent MelanomaStage IV Skin Melanoma
Terminated

All 3 trials loaded